|
|
Latest news in the field of natural sciences provided by Science Centric.
Tags: cancer, issue, researchers, scientists, study, university
Author: Click here if Science Centric is your Blog |
based on editor's review
![]() Editor reviews are provided by professional editors who evaluate a blog based on the following criteria: Frequency of Updates, Relevance of Content, Site Design, and Writing Style.
|
Survey: Men may not be adequately involved in decisions about prostate cancer screeningSep 29, 2009
Men largely make decisions about prostate cancer screening based on conversations with their clinicians, but these discussions often do not include information about the risks of testing in addition to the benefits, according to a report in the 28 Se...
New drug shows promise for those with clotting disorders: McMaster researcherDec 7, 2009
A new study provides welcome news for patients with a common clotting disorder known as venous thromboembolism (VTE)...
Scripps research team restores some function to cells from cystic fibrosis patientsDec 7, 2009
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested...
Genetic studies reveal new causes of severe obesity in childhoodDec 7, 2009
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published in Nature...
Researchers find increased dairy intake reduces risk of uterine fibroids in black womenDec 6, 2009
Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Centre found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's...
Multiple myeloma patients experience high response rate with new 3-drug combinationDec 6, 2009
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a 'highly effective regimen' in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, say researchers from...
|
||
|
||



